10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
Top 5 Health Care Stocks That May Explode In Q3
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
BioVie Presents Data For NE3107 At 2023 International Congress Of Parkinson’s Disease And Movement Disorders
New preclinical data characterizing NE3107 mechanism of action featured in oral presentation
Phamacokinetic data from Phase 2a study supports potential co-administration of NE3107 with carbidopa/levodopa
Separate
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Cadrenal Therapeutics (NASDAQ:CVKD) stock rose 22.5% to $1.58 during Friday’s after-market session. This security traded at a…
BioVie To Present Data Showing How NE3107 Potentially Regulates DNA Methylation Of Specific Genes In A Manner Highly Correlated To Observed Improvements In Cognition And Biomarkers Of Disease
BioVie Inc., (NASDAQ:BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers Benitec Biopharma (NASDAQ:BNTC) stock increased by 99.8% to $0.4 during Monday’s regular session. As of 13:37 EST,…
BioVie Presents Data Highlighting Role Of Insulin Resistance And Neuroinflammation In The Development Of Mild To Moderate In Alzheimer’s Disease
BioVie Inc., (NASDAQ:BIVI) ("BioVie" or the "Company") a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced
Benzinga Pro’s Top 5 Stocks To Watch For Friday, April 28, 2023: COST, SOFI, COIN, NET, BIVI
Costco Wholesale (COST) - The company will report monthly sales results for April on Wednesday of next week. This has been a news catalyst for Costco over the last few years -- albeit a modest
BioVie To Present Data From NE3107 Phase 2 Open-Label Trial At Society Of Biological Psychiatry Annual Meeting
BioVie Inc., (NASDAQ:BIVI) ("BioVie" or the "Company") a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver
BioVie Announces Completion Of Patient Enrollment In Phase 3 Trial Assessing NE3107 In Alzheimer’s Disease
BioVie Inc. (NASDAQ:BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced